FDA Okays Carbidopa/Levodopa ER (Rytary) in Parkinson'sFDA Okays Carbidopa/Levodopa ER (Rytary) in Parkinson's

Approval of the extended-release carbidopa-levodopa formulation was based on positive results in a trio of phase 3 studies of patients with early and advanced PD. FDA Approvals

Source: Medscape Neurology and Neurosurgery Headlines - January 8, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news